Real-time enrollment status for this idiopathic pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 5:05 AM UTC
| NCT Number | NCT07230288 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Pulmonary Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 165 participants |
| Active Locations | 10 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 18, 2026: Clinical trial NCT07230288 is currently recruiting participants. This phase2 study for idiopathic pulmonary fibrosis is actively seeking new participants at 10 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07230288 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07230288 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.